POM121L2 Inhibitors
Chemical inhibitors of POM121L2 disrupt the protein's function through various mechanisms that impede nucleocytoplasmic transport by affecting the nuclear pore complex where POM121L2 resides. Brefeldin A, for instance, targets vesicle trafficking by inhibiting the ADP-ribosylation factor, a process essential for the maintenance and localization of POM121L2 within the nuclear pore complex. Similarly, Leptomycin B impedes the nuclear export of proteins by inhibiting Exportin 1 (CRM1), thereby indirectly affecting POM121L2's role in the nuclear export system. ML-7's inhibition of myosin light chain kinase (MLCK) and the subsequent effects on cytoskeletal dynamics can alter the nuclear envelope's structural organization and, consequently, the distribution and function of POM121L2.
Paclitaxel and nocodazole exert their effects by modulating microtubule stability, which is crucial for maintaining nuclear shape and the proper functioning of the nuclear pores that include POM121L2. Paclitaxel stabilizes microtubules, potentially leading to altered nuclear rigidity and pores' functionality, while nocodazole disrupts microtubules by inhibiting their polymerization, potentially causing nuclear envelope abnormalities that impair POM121L2 function. Actin-disrupting agents like Latrunculin A, Jasplakinolide, Swinholide A, and Cytochalasin D impact the actin cytoskeleton, which supports nuclear integrity and positioning of nuclear pores. Latrunculin A and Cytochalasin D bind to actin monomers and inhibit polymerization, potentially disrupting nuclear pore complexes containing POM121L2. Conversely, Jasplakinolide and Swinholide A stabilize and sever actin filaments, respectively, leading to potential distortions in nuclear morphology that interfere with POM121L2's function. Colchicine and Vinblastine, both tubulin-binding agents, prevent microtubule polymerization, potentially leading to a compromised nuclear structure and distribution of nuclear pore complexes, thus impacting POM121L2. Lastly, Withaferin A, which targets annexin II, can lead to altered nuclear membrane dynamics, further inhibiting the function of POM121L2.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits ADP-ribosylation factor (ARF), a small GTPase involved in vesicle trafficking between the Golgi and the endoplasmic reticulum. Since POM121L2 is a nuclear pore complex protein involved in nuclear transport, the inhibition of ARF by Brefeldin A disrupts vesicle transport processes that are essential for the proper functioning and localization of POM121L2. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B is an inhibitor of Exportin 1 (CRM1), a protein that mediates nuclear export signals (NES)-dependent protein export. POM121L2, being part of the nuclear pore complex, is implicated in the nuclear export of proteins. Inhibiting CRM1 with Leptomycin B would disrupt the export of NES-containing proteins, thereby indirectly affecting the function of POM121L2 in nucleocytoplasmic transport. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase (MLCK). By inhibiting MLCK, ML-7 affects cytoskeletal dynamics and cellular morphology, which are critical for the distribution and function of nuclear pore complexes where POM121L2 is located. This inhibition could alter the structural organization of the nuclear envelope, impacting POM121L2's role in nuclear transport. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their depolymerization. Microtubules are involved in maintaining the structure of the nucleus and the distribution of nuclear pores. Stabilizing microtubules may result in altered nuclear shape and rigidity, affecting the functionality of nuclear pore complexes containing POM121L2. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules by binding to beta-tubulin and inhibiting microtubule polymerization. As microtubules support the nuclear structure and positioning of nuclear pores, nocodazole's action could lead to nuclear envelope abnormalities that impair POM121L2 function in the nuclear pore complex. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A disrupts actin polymerization by binding to actin monomers. The actin cytoskeleton is implicated in nuclear positioning and the mechanical stability of the nucleus. By disrupting actin filaments, latrunculin A could indirectly affect the structural integrity of nuclear pore complexes, including those with POM121L2. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and prevents their depolymerization. This can result in aberrant actin structures that could distort nuclear morphology and interfere with the proper functioning of nuclear pore complexes containing POM121L2. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
Swinholide A severs actin filaments and prevents actin polymerization. The actin cytoskeleton's role in maintaining nuclear architecture suggests that altering actin dynamics with swinholide A could disrupt the nuclear envelope and affect the function of POM121L2 within the nuclear pore complex. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin, preventing its polymerization into microtubules. This action can lead to a compromised nuclear structure and aberrations in the distribution and function of the nuclear pore complexes, thus impacting POM121L2's role in nucleocytoplasmic transport. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D inhibits actin polymerization and results in the disassembly of actin filaments. Since the actin cytoskeleton is integral to nuclear integrity and the positioning of nuclear pore complexes, the function of POM121L2 as a nuclear pore component could be inhibited by cytochalasin D due to changes in nuclear envelope dynamics. | ||||||